STOCK TITAN

Ginkgo Bioworks Announces Participation in Jefferies Gene Therapy/Editing Summit

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Ginkgo Bioworks Inc. (NYSE: DNA) will present at the Jefferies Gene Therapy/Editing Summit on October 27, 2021, at 3:00 p.m. Eastern Time. The company focuses on a platform for cell programming applicable to various markets, including biotechnology, pharmaceuticals, and industrial chemicals. Ginkgo has also supported COVID-19 initiatives, including vaccine optimization and testing. Investors can access the webcast and presentation replay via the company’s investor relations website.

Positive
  • Participation in the Jefferies Gene Therapy/Editing Summit showcases Ginkgo's engagement in biotechnological advancements.
  • The company's platform supports diverse applications in biotechnology, potentially expanding market reach.
Negative
  • None.

BOSTON, Oct. 20, 2021 /PRNewswire/ -- Ginkgo Bioworks Inc. (NYSE: DNA) ("Ginkgo"), which is building the leading horizontal platform for cell programming, announced today that management is scheduled to present at the Jefferies Gene Therapy/Editing Summit on Wednesday, October 27, 2021 at 3:00p.m. Eastern Time.

The webcast link and replay of the presentation can be found below as well as on the company's investor relations website at https://investors.ginkgobioworks.com.

Webcasting information: https://wsw.com/webcast/jeff208/register.aspx?conf=jeff208&page=gibi&url=https://wsw.com/webcast/jeff208/gibi/1821975

About Ginkgo Bioworks

Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization and therapeutics discovery. For more information, visit www.ginkgobioworks.com.

MEDIA CONTACT:

press@ginkgobioworks.com  

INVESTOR CONTACT:

investors@ginkgobioworks.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-participation-in-jefferies-gene-therapyediting-summit-301404504.html

SOURCE Ginkgo Bioworks

FAQ

What is the date and time of Ginkgo Bioworks' presentation at the Jefferies Summit?

Ginkgo Bioworks will present on October 27, 2021, at 3:00 p.m. Eastern Time.

Where can I watch the Ginkgo Bioworks presentation?

You can access the webcast and replay on Ginkgo's investor relations website.

What markets does Ginkgo Bioworks serve?

Ginkgo Bioworks serves markets including biotechnology, pharmaceuticals, industrial chemicals, food, and agriculture.

How is Ginkgo Bioworks contributing to COVID-19 efforts?

Ginkgo has supported COVID-19 efforts such as K-12 pooled testing and vaccine manufacturing optimization.

Ginkgo Bioworks Holdings, Inc.

NYSE:DNA

DNA Rankings

DNA Latest News

DNA Stock Data

370.74M
52.65M
6.15%
68.55%
13.18%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
BOSTON